Article(id=1329835156329836547, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835073559441697, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.02.011, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1680710400000, receivedDateStr=2023-04-06, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794987008410, onlineDateStr=2026-11-18, pubDate=1707494400000, pubDateStr=2024-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794987008410, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794987008410, creator=13701087609, updateTime=1794987008410, updator=13701087609, issue=Issue{id=1329835073559441697, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='2', pageStart='107', pageEnd='227', issueExtLink='null', onlineDate='null', pubDate='1707494400000', pubDateStr='2024-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794986988677, creator='13701087609', updateTime=1794988212209, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329840205898560208, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835073559441697, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329840205902754513, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835073559441697, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=176, endPage=180, ext={EN=ArticleExt(id=1329835156594077700, articleId=1329835156329836547, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=A case report on the use of pirfenidone in the treatment of immune checkpoint inhibitorassociated pneumonia caused by pabrizumab, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=null, authors=Jing LIN1, 2, Fahua SHI3, Xiaofei WANG1, *, authorsList=Jing LIN, Fahua SHI, Xiaofei WANG, authorCompany=null, correspAuthors=Xiaofei WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329835156854124550, articleId=1329835156329836547, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=吡非尼酮治疗帕博丽珠单抗导致的免疫检查点抑制剂相关肺炎1例, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=

68岁男性患者确诊Ⅲb期肺鳞癌,在接受2次帕博利珠单抗免疫治疗后肿瘤体积明显缩小,但同时出现免疫检查点抑制剂相关肺炎(checkpoint inhibitor pneumonitis,CIP)。早期给予大剂量激素治疗后,患者胸部CT影像学及临床症状部分缓解,后给予吡非尼酮口服(一日3次,初始每次200 mg,后逐渐加量至每次300 mg)抗纤维化治疗后患者胸部CT影像学和临床症状明显好转。本例患者使用吡非尼酮治疗CIP取得明显疗效。免疫检查点抑制剂疗效与免疫相关不良事件之间关系复杂,CIP更易发生在长期暴露于吸烟环境或患有肺部基础疾病者。吡非尼酮的广谱抗纤维化作用在非特发性肺间质纤维化型肺纤维化治疗中也取得明显效果,未来临床应用前景广阔。

, authors=林静1, 2, 施发花3, 王晓斐1, *, authorsList=林静, 施发花, 王晓斐, authorCompany=null, correspAuthors=王晓斐, authorNote=

林静,主治医师,研究方向:肺部感染性疾病和肿瘤疾病的诊治。

, correspAuthorsNote=
王晓斐,副主任医师,研究方向:肺部恶性肿瘤的综合诊治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=uvFpVpz22KrqTi4pFdbr9A==, magXml=dexHbyXbG5FpbnXZe511oA==, pdfUrl=null, pdf=ZSVGRGb/xa2/fhvw+r7V8w==, pdfFileSize=1906462, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=KfrdDSY3v49VfHN1hX8pOw==, mapNumber=null, fund=null)}, authors=[Author(id=1329835157332275218, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835157424549909, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, authorId=1329835157332275218, language=EN, stringName=Jing LIN, firstName=Jing, middleName=null, lastName=LIN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Emergency revention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China
2.Department of Pulmonary and Critical Care Medicine, the Second People's Hospital of Guizhou Province, Guiyang 550002, Guizhou Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835157491658774, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, authorId=1329835157332275218, language=CN, stringName=林静, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.上海交通大学医学院附属瑞金医院呼吸与危重症医学科,上海交通大学医学院呼吸病研究所,上海市呼吸传染应急防控与诊治重点实验室,上海 200025
2.贵州省第二人民医院呼吸与危重症医学科,贵州 贵阳 550002, bio={"content":"

林静,主治医师,研究方向:肺部感染性疾病和肿瘤疾病的诊治。

"}, bioImg=null, bioContent=

林静,主治医师,研究方向:肺部感染性疾病和肿瘤疾病的诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835157063839752, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, xref=1., ext=[AuthorCompanyExt(id=1329835157072228361, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157063839752, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Emergency revention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China), AuthorCompanyExt(id=1329835157080616970, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157063839752, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学医学院附属瑞金医院呼吸与危重症医学科,上海交通大学医学院呼吸病研究所,上海市呼吸传染应急防控与诊治重点实验室,上海 200025)]), AuthorCompany(id=1329835157185474571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, xref=2., ext=[AuthorCompanyExt(id=1329835157198057484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157185474571, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pulmonary and Critical Care Medicine, the Second People's Hospital of Guizhou Province, Guiyang 550002, Guizhou Province, China), AuthorCompanyExt(id=1329835157206446093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157185474571, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.贵州省第二人民医院呼吸与危重症医学科,贵州 贵阳 550002)])]), Author(id=1329835157554573336, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835157713956890, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, authorId=1329835157554573336, language=EN, stringName=Fahua SHI, firstName=Fahua, middleName=null, lastName=SHI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Department of Pulmonary and Critical Care Medicine, Qinghai Red Cross Hospital, Xining 810015, Qinghai Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835159328763932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, authorId=1329835157554573336, language=CN, stringName=施发花, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.青海红十字医院呼吸与危重医学科,青海 西宁 810015, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835157265166350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, xref=3., ext=[AuthorCompanyExt(id=1329835157273554959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157265166350, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Pulmonary and Critical Care Medicine, Qinghai Red Cross Hospital, Xining 810015, Qinghai Province, China), AuthorCompanyExt(id=1329835157281943568, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157265166350, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.青海红十字医院呼吸与危重医学科,青海 西宁 810015)])]), Author(id=1329835159412650014, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329835159479758880, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, authorId=1329835159412650014, language=EN, stringName=Xiaofei WANG, firstName=Xiaofei, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Emergency revention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835159555256353, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, authorId=1329835159412650014, language=CN, stringName=王晓斐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海交通大学医学院附属瑞金医院呼吸与危重症医学科,上海交通大学医学院呼吸病研究所,上海市呼吸传染应急防控与诊治重点实验室,上海 200025, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835157063839752, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, xref=1., ext=[AuthorCompanyExt(id=1329835157072228361, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157063839752, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Emergency revention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China), AuthorCompanyExt(id=1329835157080616970, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157063839752, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学医学院附属瑞金医院呼吸与危重症医学科,上海交通大学医学院呼吸病研究所,上海市呼吸传染应急防控与诊治重点实验室,上海 200025)])])], keywords=[Keyword(id=1329835159664308258, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, language=EN, orderNo=1, keyword=immune-related adverse events), Keyword(id=1329835159760777252, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, language=EN, orderNo=2, keyword=checkpoint inhibitor pneumonitis), Keyword(id=1329835159836274725, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, language=EN, orderNo=3, keyword=pirfenidone), Keyword(id=1329835159928549414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, language=CN, orderNo=1, keyword=免疫相关不良反应), Keyword(id=1329835160004046887, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, language=CN, orderNo=2, keyword=免疫检查点抑制剂相关肺炎), Keyword(id=1329835160117293096, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, language=CN, orderNo=3, keyword=吡非尼酮)], refs=[Reference(id=1329835160465420331, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Jain P, Jain C, Vamsidhar V. Role of immune-checkpoint inhibitors in lung cancer[J]. Ther Adv Respir Dis, 2018, doi: 10.1177/1753465817750075., articleTitle=null, refAbstract=null), Reference(id=1329835160528334893, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu Q, Luo X, Peng L, et al. Nivolumab versus docetaxel for previously treated advanced non-small cell lung cancer in China: a cost-effectiveness analysis[J]. Clin Drug Investig, 2020, 40(2): 129-137., articleTitle=null, refAbstract=null), Reference(id=1329835160616415278, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Reck M, Taylor F, Penrod JR, et al. Impact of nivolumab versus docetaxel on health-related quality of life andsymptoms in patients with advanced squamous non-small cell lung cancer: results from the CheckMate017 study[J]. J Thorac Oncol, 2018, 13(2): 194-204., articleTitle=null, refAbstract=null), Reference(id=1329835160691912752, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Wu YL, Lu S, Cheng Y, et al. Nivolumab versus docetaxel in a predominantly chinese patient population with previously treated advanced NSCLC: CheckMate078 randomized phase Ⅲ clinical trial[J]. J Thorac Oncol, 2019, 14(5): 867-875., articleTitle=null, refAbstract=null), Reference(id=1329835160779993137, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Hellmann MD, Paz-Ares L, Bernabe Caro R, et al. Nivolumab plus ipilimumab in advanced non-small-cell lung cancer[J]. N Engl J Med, 2019, 381(21): 2020-2031., articleTitle=null, refAbstract=null), Reference(id=1329835160863879218, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Khunger M, Rakshit S, Pasupuleti V, et al. Incidence of pneumonitis with use of programmed death 1 and programmed death-ligand 1 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis of trials[J]. Chest, 2017, 152(2): 271-281., articleTitle=null, refAbstract=null), Reference(id=1329835160918405171, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=刘倩倩, 尚利华. 晚期非小细胞肺癌免疫治疗相关不良反应与疗效的相关性研究进展[J]. 实用肿瘤学杂志, 2022, 36(5): 463-467., articleTitle=null, refAbstract=null), Reference(id=1329835160981319732, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Oxnard GR, Yang JC, Yu H, et al. TATTON: a multiarm, phase Ⅰb trial of simertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant ung cancer[J]. Ann Oncol, 2020, 31(4): 507-516., articleTitle=null, refAbstract=null), Reference(id=1329835161040039989, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Toh CK, Wong EH, Lim WT, et al. The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a etrospective analysis[J]. Chest, 2004, 126(6): 1750-1756., articleTitle=null, refAbstract=null), Reference(id=1329835161132314678, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials[J]. Lancet, 2011, 377(9779): 1760-1769., articleTitle=null, refAbstract=null), Reference(id=1329835161228783671, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Jr King TE, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis[J]. N Engl J Med, 2014, 370(22): 2083-2092., articleTitle=null, refAbstract=null), Reference(id=1329835161291698232, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=甘文华, 黄凯, 吕紫薇, 等. 吡非尼酮和尼达尼布体外抗肺纤维化作用[J]. 中国药理学通报, 2019, 35(10): 1370-1375., articleTitle=null, refAbstract=null), Reference(id=1329835161358807097, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=刘丽云, 赵娜, 王琳琳, 等. 吡非尼酮和尼达尼布药物的研究进展[J]. 山西化工, 2022, 42(2): 49-51., articleTitle=null, refAbstract=null), Reference(id=1329835161425915962, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=罗丽珊, 杨敬源, 林俊鸿. 吡非尼酮通过抑制热休克蛋白90的表达改善肺纤维化[J]. 齐齐哈尔医学院学报, 2022, 4(15): 1401., articleTitle=null, refAbstract=null), Reference(id=1329835161501413435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Grattendick KJ, Nakashima JM, Feng L, et al. Effects of three anti-TNF-α drugs: etanercept, infliximab and pirfenidone on release of TNF-α in medium and TNF-α associated with the cell in vitro[J]. Int Immunopharmacol, 2008, 8(5): 679-687., articleTitle=null, refAbstract=null), Reference(id=1329835161572716604, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=吕紫薇, 黄凯, 甘文华, 等. 吡非尼酮和尼达尼布抑制博来霉素诱导的小鼠肺纤维化药效比较[J]. 中国病理生理杂志, 2020, 36(1): 112-118., articleTitle=null, refAbstract=null), Reference(id=1329835161656602685, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Yu W, Guo F, Song X. Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models[J]. Pharm Biol, 2017, 55(1): 450-455., articleTitle=null, refAbstract=null), Reference(id=1329835161723711550, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Gurujeyalakshmi G, Hollinger MA, Giri SN. Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level[J]. Am J Physiol, 1999, 276(2): L311-L318., articleTitle=null, refAbstract=null), Reference(id=1329835161790820415, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=邹臻寰, 张小红, 李镇洲, 等. 吡非尼酮抑制转化生长因子β1/转化生长因子活化激酶1通路改善大鼠腹膜纤维化[J]. 中华高血压杂志, 2021, 29(5): 460-469., articleTitle=null, refAbstract=null), Reference(id=1329835161853734976, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Ueshima E, m Fujimori M, Kodama H, et al. Macrophage-secreted TGF-β1 contributest of ibrobla stactivation andureter alastric-ture after ablation injury[J]. Am J Physiol Renal Physiol, 2019, 317(7): F52-F64., articleTitle=null, refAbstract=null), Reference(id=1329835161979564097, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=魏桂莲, 崔彩云, 张泽丽, 等. 吡非尼酮联合常规内科治疗在慢性阻塞性肺疾病继发肺间质纤维化病变的临床效果分析[J]. 中外医学研究, 2022, 20(32): 1-6., articleTitle=null, refAbstract=null), Reference(id=1329835162143141954, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=周萌, 魏华. 吡非尼酮治疗结缔组织病继发间质性肺病临床疗效研究[J]. 扬州职业大学学报, 2020, 24(4): 49-52., articleTitle=null, refAbstract=null), Reference(id=1329835163774726211, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=杨磊, 刘佳琦, 边原, 等. 吡非尼酮治疗新型冠状病毒导致肺纤维化的可能性[J]. 中国新药与临床杂志, 2021, 40(1): 8-12., articleTitle=null, refAbstract=null), Reference(id=1329835163883778116, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=于海明, 李进英, 于兰, 等. PD-1单抗导致免疫检查点抑制剂相关肺炎1例——吡非尼酮治疗的安全性和有效性[J]. 中国肺癌杂志, 2021, 24(7): 519-525., articleTitle=null, refAbstract=null), Reference(id=1329835163946692677, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=陈华林, 刘美莲, 罗怡平, 等. 吡非尼酮治疗PD-1抑制剂信迪利单抗相关免疫性肺炎1例[J]. 肿瘤学杂志, 2021, 27(7): 601-604., articleTitle=null, refAbstract=null), Reference(id=1329835164026384454, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=杨阳, 周秋云, 宋映容, 等. 基于openFDA对吡非尼酮和尼达尼布药品不良反应的比较分析[J]. 药学与临床研究, 2022, 30(3): 263-266., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329835160293453865, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, awardId=81702250, language=CN, fundingSource=国家自然科学基金(81702250), fundOrder=null, country=null), Fund(id=1329835160360562730, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, awardId=320.6750.19088-97, language=CN, fundingSource=吴阶平医学基金会临床科研专项资金基金(320.6750.19088-97), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329835157063839752, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, xref=1., ext=[AuthorCompanyExt(id=1329835157072228361, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157063839752, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Emergency revention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China), AuthorCompanyExt(id=1329835157080616970, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157063839752, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学医学院附属瑞金医院呼吸与危重症医学科,上海交通大学医学院呼吸病研究所,上海市呼吸传染应急防控与诊治重点实验室,上海 200025)]), AuthorCompany(id=1329835157185474571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, xref=2., ext=[AuthorCompanyExt(id=1329835157198057484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157185474571, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pulmonary and Critical Care Medicine, the Second People's Hospital of Guizhou Province, Guiyang 550002, Guizhou Province, China), AuthorCompanyExt(id=1329835157206446093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157185474571, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.贵州省第二人民医院呼吸与危重症医学科,贵州 贵阳 550002)]), AuthorCompany(id=1329835157265166350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, xref=3., ext=[AuthorCompanyExt(id=1329835157273554959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157265166350, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Pulmonary and Critical Care Medicine, Qinghai Red Cross Hospital, Xining 810015, Qinghai Province, China), AuthorCompanyExt(id=1329835157281943568, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157265166350, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.青海红十字医院呼吸与危重医学科,青海 西宁 810015)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.02.011, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.02.011, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.02.011, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.02.011, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1707494400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
吡非尼酮治疗帕博丽珠单抗导致的免疫检查点抑制剂相关肺炎1例
林静 1, 2 , 施发花 3 , 王晓斐 1, *
世界临床药物 | 研究论文 2024,45(2): 176-180
收起
收藏切换
世界临床药物 |研究论文 2024 , 45 (2) : 176 -180
吡非尼酮治疗帕博丽珠单抗导致的免疫检查点抑制剂相关肺炎1例
全屏
[Author(id=1329835157332275218, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835157424549909, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, authorId=1329835157332275218, language=EN, stringName=Jing LIN, firstName=Jing, middleName=null, lastName=LIN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Emergency revention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China
2.Department of Pulmonary and Critical Care Medicine, the Second People's Hospital of Guizhou Province, Guiyang 550002, Guizhou Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835157491658774, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, authorId=1329835157332275218, language=CN, stringName=林静, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.上海交通大学医学院附属瑞金医院呼吸与危重症医学科,上海交通大学医学院呼吸病研究所,上海市呼吸传染应急防控与诊治重点实验室,上海 200025
2.贵州省第二人民医院呼吸与危重症医学科,贵州 贵阳 550002, bio={"content":"

林静,主治医师,研究方向:肺部感染性疾病和肿瘤疾病的诊治。

"}, bioImg=null, bioContent=

林静,主治医师,研究方向:肺部感染性疾病和肿瘤疾病的诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835157063839752, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, xref=1., ext=[AuthorCompanyExt(id=1329835157072228361, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157063839752, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Emergency revention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China), AuthorCompanyExt(id=1329835157080616970, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157063839752, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学医学院附属瑞金医院呼吸与危重症医学科,上海交通大学医学院呼吸病研究所,上海市呼吸传染应急防控与诊治重点实验室,上海 200025)]), AuthorCompany(id=1329835157185474571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, xref=2., ext=[AuthorCompanyExt(id=1329835157198057484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157185474571, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pulmonary and Critical Care Medicine, the Second People's Hospital of Guizhou Province, Guiyang 550002, Guizhou Province, China), AuthorCompanyExt(id=1329835157206446093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157185474571, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.贵州省第二人民医院呼吸与危重症医学科,贵州 贵阳 550002)])]), Author(id=1329835157554573336, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835157713956890, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, authorId=1329835157554573336, language=EN, stringName=Fahua SHI, firstName=Fahua, middleName=null, lastName=SHI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Department of Pulmonary and Critical Care Medicine, Qinghai Red Cross Hospital, Xining 810015, Qinghai Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835159328763932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, authorId=1329835157554573336, language=CN, stringName=施发花, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.青海红十字医院呼吸与危重医学科,青海 西宁 810015, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835157265166350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, xref=3., ext=[AuthorCompanyExt(id=1329835157273554959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157265166350, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Pulmonary and Critical Care Medicine, Qinghai Red Cross Hospital, Xining 810015, Qinghai Province, China), AuthorCompanyExt(id=1329835157281943568, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157265166350, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.青海红十字医院呼吸与危重医学科,青海 西宁 810015)])]), Author(id=1329835159412650014, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329835159479758880, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, authorId=1329835159412650014, language=EN, stringName=Xiaofei WANG, firstName=Xiaofei, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Emergency revention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835159555256353, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, authorId=1329835159412650014, language=CN, stringName=王晓斐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海交通大学医学院附属瑞金医院呼吸与危重症医学科,上海交通大学医学院呼吸病研究所,上海市呼吸传染应急防控与诊治重点实验室,上海 200025, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835157063839752, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, xref=1., ext=[AuthorCompanyExt(id=1329835157072228361, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157063839752, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Emergency revention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China), AuthorCompanyExt(id=1329835157080616970, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835156329836547, companyId=1329835157063839752, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学医学院附属瑞金医院呼吸与危重症医学科,上海交通大学医学院呼吸病研究所,上海市呼吸传染应急防控与诊治重点实验室,上海 200025)])])]
林静1, 2, 施发花3, 王晓斐1, *
作者信息
  • 1.上海交通大学医学院附属瑞金医院呼吸与危重症医学科,上海交通大学医学院呼吸病研究所,上海市呼吸传染应急防控与诊治重点实验室,上海 200025
  • 2.贵州省第二人民医院呼吸与危重症医学科,贵州 贵阳 550002
  • 3.青海红十字医院呼吸与危重医学科,青海 西宁 810015
通讯作者:
王晓斐,副主任医师,研究方向:肺部恶性肿瘤的综合诊治。
作者简介:

林静,主治医师,研究方向:肺部感染性疾病和肿瘤疾病的诊治。

A case report on the use of pirfenidone in the treatment of immune checkpoint inhibitorassociated pneumonia caused by pabrizumab
Jing LIN1, 2, Fahua SHI3, Xiaofei WANG1, *
Affiliations
  • 1.Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Emergency revention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China
  • 2.Department of Pulmonary and Critical Care Medicine, the Second People's Hospital of Guizhou Province, Guiyang 550002, Guizhou Province, China
  • 3.Department of Pulmonary and Critical Care Medicine, Qinghai Red Cross Hospital, Xining 810015, Qinghai Province, China
出版时间: 2024-02-10 doi: 10.13683/j.wph.2024.02.011
文章导航
收藏切换

68岁男性患者确诊Ⅲb期肺鳞癌,在接受2次帕博利珠单抗免疫治疗后肿瘤体积明显缩小,但同时出现免疫检查点抑制剂相关肺炎(checkpoint inhibitor pneumonitis,CIP)。早期给予大剂量激素治疗后,患者胸部CT影像学及临床症状部分缓解,后给予吡非尼酮口服(一日3次,初始每次200 mg,后逐渐加量至每次300 mg)抗纤维化治疗后患者胸部CT影像学和临床症状明显好转。本例患者使用吡非尼酮治疗CIP取得明显疗效。免疫检查点抑制剂疗效与免疫相关不良事件之间关系复杂,CIP更易发生在长期暴露于吸烟环境或患有肺部基础疾病者。吡非尼酮的广谱抗纤维化作用在非特发性肺间质纤维化型肺纤维化治疗中也取得明显效果,未来临床应用前景广阔。

免疫相关不良反应  /  免疫检查点抑制剂相关肺炎  /  吡非尼酮
immune-related adverse events  /  checkpoint inhibitor pneumonitis  /  pirfenidone
林静, 施发花, 王晓斐. 吡非尼酮治疗帕博丽珠单抗导致的免疫检查点抑制剂相关肺炎1例. 世界临床药物, 2024 , 45 (2) : 176 -180 . DOI: 10.13683/j.wph.2024.02.011
Jing LIN, Fahua SHI, Xiaofei WANG. A case report on the use of pirfenidone in the treatment of immune checkpoint inhibitorassociated pneumonia caused by pabrizumab[J]. World Clinical Drug, 2024 , 45 (2) : 176 -180 . DOI: 10.13683/j.wph.2024.02.011
  • 国家自然科学基金(81702250)
  • 吴阶平医学基金会临床科研专项资金基金(320.6750.19088-97)
参考文献 引证文献
排序方式:
[1]
Jain P, Jain C, Vamsidhar V. Role of immune-checkpoint inhibitors in lung cancer[J]. Ther Adv Respir Dis, 2018, doi: 10.1177/1753465817750075.
[2]
Liu Q, Luo X, Peng L, et al. Nivolumab versus docetaxel for previously treated advanced non-small cell lung cancer in China: a cost-effectiveness analysis[J]. Clin Drug Investig, 2020, 40(2): 129-137.
[3]
Reck M, Taylor F, Penrod JR, et al. Impact of nivolumab versus docetaxel on health-related quality of life andsymptoms in patients with advanced squamous non-small cell lung cancer: results from the CheckMate017 study[J]. J Thorac Oncol, 2018, 13(2): 194-204.
[4]
Wu YL, Lu S, Cheng Y, et al. Nivolumab versus docetaxel in a predominantly chinese patient population with previously treated advanced NSCLC: CheckMate078 randomized phase Ⅲ clinical trial[J]. J Thorac Oncol, 2019, 14(5): 867-875.
[5]
Hellmann MD, Paz-Ares L, Bernabe Caro R, et al. Nivolumab plus ipilimumab in advanced non-small-cell lung cancer[J]. N Engl J Med, 2019, 381(21): 2020-2031.
[6]
Khunger M, Rakshit S, Pasupuleti V, et al. Incidence of pneumonitis with use of programmed death 1 and programmed death-ligand 1 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis of trials[J]. Chest, 2017, 152(2): 271-281.
[7]
刘倩倩, 尚利华. 晚期非小细胞肺癌免疫治疗相关不良反应与疗效的相关性研究进展[J]. 实用肿瘤学杂志, 2022, 36(5): 463-467.
[8]
Oxnard GR, Yang JC, Yu H, et al. TATTON: a multiarm, phase Ⅰb trial of simertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant ung cancer[J]. Ann Oncol, 2020, 31(4): 507-516.
[9]
Toh CK, Wong EH, Lim WT, et al. The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a etrospective analysis[J]. Chest, 2004, 126(6): 1750-1756.
[10]
Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials[J]. Lancet, 2011, 377(9779): 1760-1769.
[11]
Jr King TE, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis[J]. N Engl J Med, 2014, 370(22): 2083-2092.
[12]
甘文华, 黄凯, 吕紫薇, 等. 吡非尼酮和尼达尼布体外抗肺纤维化作用[J]. 中国药理学通报, 2019, 35(10): 1370-1375.
[13]
刘丽云, 赵娜, 王琳琳, 等. 吡非尼酮和尼达尼布药物的研究进展[J]. 山西化工, 2022, 42(2): 49-51.
[14]
罗丽珊, 杨敬源, 林俊鸿. 吡非尼酮通过抑制热休克蛋白90的表达改善肺纤维化[J]. 齐齐哈尔医学院学报, 2022, 4(15): 1401.
[15]
Grattendick KJ, Nakashima JM, Feng L, et al. Effects of three anti-TNF-α drugs: etanercept, infliximab and pirfenidone on release of TNF-α in medium and TNF-α associated with the cell in vitro[J]. Int Immunopharmacol, 2008, 8(5): 679-687.
[16]
吕紫薇, 黄凯, 甘文华, 等. 吡非尼酮和尼达尼布抑制博来霉素诱导的小鼠肺纤维化药效比较[J]. 中国病理生理杂志, 2020, 36(1): 112-118.
[17]
Yu W, Guo F, Song X. Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models[J]. Pharm Biol, 2017, 55(1): 450-455.
[18]
Gurujeyalakshmi G, Hollinger MA, Giri SN. Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level[J]. Am J Physiol, 1999, 276(2): L311-L318.
[19]
邹臻寰, 张小红, 李镇洲, 等. 吡非尼酮抑制转化生长因子β1/转化生长因子活化激酶1通路改善大鼠腹膜纤维化[J]. 中华高血压杂志, 2021, 29(5): 460-469.
[20]
Ueshima E, m Fujimori M, Kodama H, et al. Macrophage-secreted TGF-β1 contributest of ibrobla stactivation andureter alastric-ture after ablation injury[J]. Am J Physiol Renal Physiol, 2019, 317(7): F52-F64.
[21]
魏桂莲, 崔彩云, 张泽丽, 等. 吡非尼酮联合常规内科治疗在慢性阻塞性肺疾病继发肺间质纤维化病变的临床效果分析[J]. 中外医学研究, 2022, 20(32): 1-6.
[22]
周萌, 魏华. 吡非尼酮治疗结缔组织病继发间质性肺病临床疗效研究[J]. 扬州职业大学学报, 2020, 24(4): 49-52.
[23]
杨磊, 刘佳琦, 边原, 等. 吡非尼酮治疗新型冠状病毒导致肺纤维化的可能性[J]. 中国新药与临床杂志, 2021, 40(1): 8-12.
[24]
于海明, 李进英, 于兰, 等. PD-1单抗导致免疫检查点抑制剂相关肺炎1例——吡非尼酮治疗的安全性和有效性[J]. 中国肺癌杂志, 2021, 24(7): 519-525.
[25]
陈华林, 刘美莲, 罗怡平, 等. 吡非尼酮治疗PD-1抑制剂信迪利单抗相关免疫性肺炎1例[J]. 肿瘤学杂志, 2021, 27(7): 601-604.
[26]
杨阳, 周秋云, 宋映容, 等. 基于openFDA对吡非尼酮和尼达尼布药品不良反应的比较分析[J]. 药学与临床研究, 2022, 30(3): 263-266.
2024年第45卷第2期
18
5
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.02.011
  • 接收时间:2023-04-06
  • 首发时间:2026-11-18
  • 出版时间:2024-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-04-06
基金
国家自然科学基金(81702250)
吴阶平医学基金会临床科研专项资金基金(320.6750.19088-97)
作者信息
    1.上海交通大学医学院附属瑞金医院呼吸与危重症医学科,上海交通大学医学院呼吸病研究所,上海市呼吸传染应急防控与诊治重点实验室,上海 200025
    2.贵州省第二人民医院呼吸与危重症医学科,贵州 贵阳 550002
    3.青海红十字医院呼吸与危重医学科,青海 西宁 810015

通讯作者:

王晓斐,副主任医师,研究方向:肺部恶性肿瘤的综合诊治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.02.011
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏